Veterinary vaccine nanotechnology: pulmonary and nasal delivery in livestock animals

[1]  S. Palma,et al.  Spray dried microspheres based on chitosan: A promising new carrier for intranasal administration of polymeric antigen BLSOmp31 for prevention of ovine brucellosis. , 2016, Materials science & engineering. C, Materials for biological applications.

[2]  J. DeSimone,et al.  Nanoparticle surface charge impacts distribution, uptake and lymph node trafficking by pulmonary antigen-presenting cells. , 2016, Nanomedicine : nanotechnology, biology, and medicine.

[3]  J. Maina.  Structural and Biomechanical Properties of the Exchange Tissue of the Avian Lung , 2015, Anatomical record.

[4]  B. Earley,et al.  Comparing the immune response to a novel intranasal nanoparticle PLGA vaccine and a commercial BPI3V vaccine in dairy calves , 2015, BMC Veterinary Research.

[5]  M. Jeyanathan,et al.  AdHu5Ag85A Respiratory Mucosal Boost Immunization Enhances Protection against Pulmonary Tuberculosis in BCG-Primed Non-Human Primates , 2015, PloS one.

[6]  Abdelwahab Omri,et al.  Nasal and pulmonary vaccine delivery using particulate carriers , 2015, Expert opinion on drug delivery.

[7]  M. Foldvari,et al.  Protection of Neonatal Broiler Chickens Following in ovo Delivery of Oligodeoxynucleotides Containing CpG Motifs (CpG-ODN) Formulated with Carbon Nanotubes or Liposomes , 2015, Avian diseases.

[8]  S. H. van der Burg,et al.  CD40-targeted dendritic cell delivery of PLGA-nanoparticle vaccines induce potent anti-tumor responses. , 2015, Biomaterials.

[9]  Pankaj Kumar,et al.  Bovine adenovirus-3 as a vaccine delivery vehicle , 2014, Vaccine.

[10]  P. Rota,et al.  Safety and immunogenicity of dry powder measles vaccine administered by inhalation: a randomized controlled Phase I clinical trial. , 2014, Vaccine.

[11]  W. Hinrichs,et al.  Pulmonary immunization of chickens using non-adjuvanted spray-freeze dried whole inactivated virus vaccine completely protects against highly pathogenic H5N1 avian influenza virus. , 2014, Vaccine.

[12]  D. Klinman,et al.  Clinical evaluation of CpG oligonucleotides as adjuvants for vaccines targeting infectious diseases and cancer. , 2014, Vaccine.

[13]  Joo Yeon Park,et al.  Nanotechnology and vaccine development , 2014 .

[14]  Tracy K. Pettinger,et al.  Nanopharmaceuticals (part 1): products on the market , 2014, International journal of nanomedicine.

[15]  L. Babiuk,et al.  Mucosal immunization of calves with recombinant bovine adenovirus-3 coexpressing truncated form of bovine herpesvirus-1 gD and bovine IL-6. , 2014, Vaccine.

[16]  M. A. Amini,et al.  Foot and Mouth Disease virus-loaded fungal chitosan nanoparticles for intranasal administration: impact of formulation on physicochemical and immunological characteristics , 2014, Pharmaceutical development and technology.

[17]  D. Kapczynski,et al.  Adjuvant Effects of Chitosan and Calcium Phosphate Particles in an Inactivated Newcastle Disease Vaccine , 2014, Avian diseases.

[18]  R. N. Gürsoy,et al.  Chitosan-based systems for intranasal immunization against foot-and-mouth disease , 2014, Pharmaceutical development and technology.

[19]  Magdalena Plebanski,et al.  Differential Uptake of Nanoparticles and Microparticles by Pulmonary APC Subsets Induces Discrete Immunological Imprints , 2013, The Journal of Immunology.

[20]  T. Monath.  Vaccines against diseases transmitted from animals to humans: A one health paradigm , 2013, Vaccine.

[21]  S. Rautenschlein,et al.  Mucosal application of cationic poly(D,L-lactide-co-glycolide) microparticles as carriers of DNA vaccine and adjuvants to protect chickens against infectious bursal disease. , 2013, Vaccine.

[22]  W. Gu,et al.  Re-considering how particle size and other properties of antigen-adjuvant complexes impact on the immune responses. , 2013, Journal of colloid and interface science.

[23]  H. McShane,et al.  Evaluation of the Safety and Immunogenicity of a Candidate Tuberculosis Vaccine, MVA85A, Delivered by Aerosol to the Lungs of Macaques , 2013, Clinical and Vaccine Immunology.

[24]  S. Worgall,et al.  Adenovirus-Based Vaccine with Epitopes Incorporated in Novel Fiber Sites to Induce Protective Immunity against Pseudomonas aeruginosa , 2013, PloS one.

[25]  A. Potter,et al.  Carrier molecules for use in veterinary vaccines. , 2013, Vaccine.

[26]  A. Panda,et al.  Nanotechnology in Vaccine Development , 2012, Proceedings of the National Academy of Sciences, India Section B: Biological Sciences.

[27]  L. Babiuk,et al.  Enhanced immune responses and protection by vaccination with respiratory syncytial virus fusion protein formulated with CpG oligodeoxynucleotide and innate defense regulator peptide in polyphosphazene microparticles. , 2012, Vaccine.

[28]  N. Lycke.  Recent progress in mucosal vaccine development: potential and limitations , 2012, Nature Reviews Immunology.

[29]  O. Raabe,et al.  Study of Nebulization Delivery of Aerosolized Fluorescent Microspheres to the Avian Respiratory Tract , 2012, Avian diseases.

[30]  L. Dupuis,et al.  Efficacy of intranasal and spray delivery of adjuvanted live vaccine against infectious bronchitis virus in experimentally infected poultry , 2012, Procedia in Vaccinology.

[31]  G. Dai,et al.  CD40 ligand enhances immunogenicity of vector-based vaccines in immunocompetent and CD4+ T cell deficient individuals. , 2012, Vaccine.

[32]  J. Roth.  Veterinary Vaccines and Their Importance to Animal Health and Public Health , 2011, Procedia in Vaccinology.

[33]  C. Figdor,et al.  The influence of PEG chain length and targeting moiety on antibody-mediated delivery of nanoparticle vaccines to human dendritic cells. , 2011, Biomaterials.

[34]  B. Narasimhan,et al.  Mannose-functionalized "pathogen-like" polyanhydride nanoparticles target C-type lectin receptors on dendritic cells. , 2011, Molecular pharmaceutics.

[35]  R. Tiner,et al.  Aerosol drug delivery: developments in device design and clinical use , 2011, The Lancet.

[36]  L. Kaminskas,et al.  New developments in dry powder pulmonary vaccine delivery. , 2011, Trends in biotechnology.

[37]  C. Surber,et al.  Nasal drug delivery in humans. , 2011, Current problems in dermatology.

[38]  M. J. Santander-Ortega,et al.  Chitosan nanocapsules: Effect of chitosan molecular weight and acetylation degree on electrokinetic behaviour and colloidal stability. , 2011, Colloids and surfaces. B, Biointerfaces.

[39]  C. Andrews,et al.  Genetic immunization in the lung induces potent local and systemic immune responses , 2010, Proceedings of the National Academy of Sciences.

[40]  Wolfgang G Kreyling,et al.  Nanoparticles in the lung , 2010, Nature Biotechnology.

[41]  A. Ozkul,et al.  Chitosan based delivery systems for mucosal immunization against bovine herpesvirus 1 (BHV-1). , 2010, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[42]  Hak Soo Choi,et al.  Rapid translocation of nanoparticles from the lung airspaces to the body , 2010, Nature Biotechnology.

[43]  M. Jeyanathan,et al.  Respiratory mucosal immunization with adenovirus gene transfer vector induces helper CD4 T cell‐independent protective immunity , 2010, The journal of gene medicine.

[44]  Wentao Gao,et al.  Assessment of Route of Administration and Dose Escalation for an Adenovirus-Based Influenza A Virus (H5N1) Vaccine in Chickens , 2010, Clinical and Vaccine Immunology.

[45]  H W Frijlink,et al.  A comparison between spray drying and spray freeze drying to produce an influenza subunit vaccine powder for inhalation. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[46]  Fernando Albericio,et al.  Targeted PLGA nano- but not microparticles specifically deliver antigen to human dendritic cells via DC-SIGN in vitro. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[47]  T. Fahmy,et al.  Application of nanotechnologies for improved immune response against infectious diseases in the developing world. , 2010, Advanced drug delivery reviews.

[48]  Fakhrul Ahsan,et al.  Particle Size Influences the Immune Response Produced by Hepatitis B Vaccine Formulated in Inhalable Particles , 2010, Pharmaceutical Research.

[49]  D. Lo,et al.  Claudin 4-targeted protein incorporated into PLGA nanoparticles can mediate M cell targeted delivery. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[50]  R. Muzzarelli.  Chitins and Chitosans as Immunoadjuvants and Non-Allergenic Drug Carriers , 2010, Marine drugs.

[51]  G. Scheuch,et al.  Treatment of systemic diseases by inhalation of biomolecule aerosols. , 2009, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.

[52]  Yi-you Huang,et al.  Effect of lipopolysaccharide on intranasal administration of liposomal Newcastle disease virus vaccine to SPF chickens. , 2009, Veterinary immunology and immunopathology.

[53]  Yi-you Huang,et al.  Mucoadhesive liposomes for intranasal immunization with an avian influenza virus vaccine in chickens. , 2009, Biomaterials.

[54]  T. Noro,et al.  Vaccination of Chickens with Liposomal Inactivated Avian Pathogenic Escherichia coli (APEC) Vaccine by Eye Drop or Coarse Spray Administration , 2009, Avian diseases.

[55]  J. Sallenave,et al.  Intranasal Mucosal Boosting with an Adenovirus-Vectored Vaccine Markedly Enhances the Protection of BCG-Primed Guinea Pigs against Pulmonary Tuberculosis , 2009, PloS one.

[56]  A. Nasir.  Nanotechnology in vaccine development: a step forward. , 2009, The Journal of investigative dermatology.

[57]  M. Garcia‐Fuentes,et al.  Nanoparticles for nasal vaccination. , 2009, Advanced drug delivery reviews.

[58]  S. Duke,et al.  In ovo treatment with CpG oligodeoxynucleotides decreases colonization of Salmonella enteriditis in broiler chickens. , 2009, Veterinary immunology and immunopathology.

[59]  L. Babiuk,et al.  Protection of Neonatal Broiler Chicks Against Salmonella Typhimurium Septicemia by DNA Containing CpG Motifs , 2008, Avian diseases.

[60]  J. Remon,et al.  Vaccination of broiler chickens with dispersed dry powder vaccines as an alternative for liquid spray and aerosol vaccination. , 2008, Vaccine.

[61]  R. Löbenberg,et al.  Targeted delivery of nanoparticles for the treatment of lung diseases. , 2008, Advanced drug delivery reviews.

[62]  B. Bloom,et al.  Immunization by a bacterial aerosol , 2008, Proceedings of the National Academy of Sciences.

[63]  Kate E. Jones,et al.  Global trends in emerging infectious diseases , 2008, Nature.

[64]  W. Hinrichs,et al.  Pulmonary delivery of an inulin-stabilized influenza subunit vaccine prepared by spray-freeze drying induces systemic, mucosal humoral as well as cell-mediated immune responses in BALB/c mice. , 2007, Vaccine.

[65]  P. Pastoret,et al.  Pastoret and Gregers Jungersen Current Status of Veterinary Vaccines Current Status of Veterinary Vaccines , 2022 .

[66]  J. Schlom,et al.  Chitosan solution enhances both humoral and cell-mediated immune responses to subcutaneous vaccination. , 2007, Vaccine.

[67]  C. Vervaet,et al.  Deposition of differently sized airborne microspheres in the respiratory tract of chickens , 2006, Avian pathology : journal of the W.V.P.A.

[68]  K. Pinkerton,et al.  An Aerosolized Fluorescent Microsphere Technique for Evaluating Particle Deposition in the Avian Respiratory Tract , 2006, Avian diseases.

[69]  L. Babiuk,et al.  Mucosal delivery of vaccines in domestic animals. , 2006, Veterinary research.

[70]  James D. Campbell,et al.  Needle-free vaccine delivery. , 2006, Advanced drug delivery reviews.

[71]  H. Shams.  Recent developments in veterinary vaccinology. , 2005, Veterinary journal.

[72]  M. Baca-Estrada,et al.  Intranasal immunization using biphasic lipid vesicles as delivery systems for OmlA bacterial protein antigen and CpG oligonucleotides adjuvant in a mouse model , 2005, The Journal of pharmacy and pharmacology.

[73]  Z. Xing,et al.  Mechanisms of Mucosal and Parenteral Tuberculosis Vaccinations: Adenoviral-Based Mucosal Immunization Preferentially Elicits Sustained Accumulation of Immune Protective CD4 and CD8 T Cells within the Airway Lumen1 , 2005, The Journal of Immunology.

[74]  L. Babiuk,et al.  Protection of Neonatal Chicks Against a Lethal Challenge of Escherichia coli Using DNA Containing Cytosine-Phosphodiester-Guanine Motifs , 2004, Avian diseases.

[75]  D. Buxton,et al.  Intranasal immunisation with Toxoplasma gondii tachyzoite antigen encapsulated into PLG microspheres induces humoral and cell-mediated immunity in sheep. , 2004, Vaccine.

[76]  T. Vandamme,et al.  Issues and challenges in developing ruminal drug delivery systems. , 2004, Advanced drug delivery reviews.

[77]  Bror Morein,et al.  Current status and potential application of ISCOMs in veterinary medicine. , 2004, Advanced drug delivery reviews.

[78]  Kozo Takayama,et al.  Novel Chitosan Particles and Chitosan-Coated Emulsions Inducing Immune Response via Intranasal Vaccine Delivery , 2004, Pharmaceutical Research.

[79]  L. Illum.  Nasal drug delivery--possibilities, problems and solutions. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[80]  S. Rockman,et al.  Intranasal vaccination with ISCOMATRIX adjuvanted influenza vaccine. , 2003, Vaccine.

[81]  L. Babiuk,et al.  Protection of Chickens against Escherichia coli Infections by DNA Containing CpG Motifs , 2003, Infection and Immunity.

[82]  M. Rathbone,et al.  Modified release drug delivery in veterinary medicine. , 2002, Drug discovery today.

[83]  M. Lemaire,et al.  Induction of protective immunity to bovine herpesvirus type 1 in cattle by intranasal administration of replication-defective human adenovirus type 5 expressing glycoprotein gC or gD. , 2002, Vaccine.

[84]  T. Bowersock,et al.  Induction of systemic and mucosal immune response in cattle by intranasal administration of pig serum albumin in alginate microparticles. , 2001, Veterinary immunology and immunopathology.

[85]  M. Pearse,et al.  Intranasal immunisation with influenza-ISCOM induces strong mucosal as well as systemic antibody and cytotoxic T-lymphocyte responses. , 2001, Vaccine.

[86]  J. Hohlfeld,et al.  Pulmonary surfactant in birds: coping with surface tension in a tubular lung. , 2001, American journal of physiology. Regulatory, integrative and comparative physiology.

[87]  J. V. van Oirschot.  Vaccinology: Present and future of veterinary viral vaccinology: A review , 2001, The Veterinary quarterly.

[88]  L. Babiuk,et al.  Adenoviruses as vectors for delivering vaccines to mucosal surfaces , 2000, Journal of Biotechnology.

[89]  Gurny,et al.  Formulation and technology aspects of conrolled drug delivery in animals. , 2000, Pharmaceutical science & technology today.

[90]  L. Babiuk,et al.  Mucosal immunization of calves with recombinant bovine adenovirus-3: induction of protective immunity to bovine herpesvirus-1. , 1999, The Journal of general virology.

[91]  S. Michalek,et al.  Induction of protective immune responses against Venezuelan equine encephalitis (VEE) virus aerosol challenge with microencapsulated VEE virus vaccine. , 1998, Vaccine.

[92]  M. Suckow,et al.  In vivo absorption of aluminium-containing vaccine adjuvants using 26Al. , 1997, Vaccine.

[93]  C. Densmore,et al.  Aerosol gene therapy , 2003, Molecular biotechnology.

[94]  M. Trudel,et al.  Control of infectious bovine rhinotracheitis in calves with a BHV-1 subunit-ISCOM vaccine. , 1988, Vaccine.

[95]  S. Kleven,et al.  Aerosol vaccination against Newcastle disease. II. Effect of vaccine diluents. , 1976, Avian diseases.

[96]  E. L. Besch,et al.  Airborne-particle deposition in the respiratory tract of chickens. , 1974, Poultry science.

[97]  F. Haesebrouck,et al.  Administration of a Salmonella Enteritidis ΔhilAssrAfliG strain by coarse spray to newly hatched broilers reduces colonization and shedding of a Salmonella Enteritidis challenge strain. , 2015, Poultry science.

[98]  L. Babiuk,et al.  Recombinant Bovine Adenovirus-3 Co-Expressing Bovine Respiratory Syncytial Virus Glycoprotein G and Truncated Glycoprotein gD of Bovine Herpesvirus-1 Induce Immune Responses in Cotton Rats , 2014, Molecular Biotechnology.

[99]  S. Gallorini,et al.  Concepts in Mucosal Immunity and Mucosal Vaccines , 2014 .

[100]  P. Couvreur.  Nanoparticles in drug delivery: past, present and future. , 2013, Advanced drug delivery reviews.

[101]  L. Babiuk,et al.  Enhancement of immunoprotective effect of CpG-ODN by formulation with polyphosphazenes against E. coli septicemia in neonatal chickens. , 2009, Current drug delivery.

[102]  Peter R. Byron,et al.  Inhaling medicines: delivering drugs to the body through the lungs , 2007, Nature Reviews Drug Discovery.

[103]  S. Kleven,et al.  Aerosol vaccination against Newcastle disease. I. Studies on particle size. , 1976, Avian diseases.